Table 3:

Adverse events related or possibly related to the intervention.

Adverse eventTotal (n = 23)TRE (n = 10)HE (n = 13)
Hunger15 (17%)12 (27%)3 (7%)
Fatigue2 (2%)1 (2%)1 (2%)
Irritability5 (6%)4 (10%)1 (2%)
Headache1 (1%)1 (2%)0 (0%)
Gastrointestinal distress11 (13%)5 (11%)6 (14%)
Dizziness1 (1%)1 (2%)0 (0%)
Lightheadedness9 (10%)5 (11%)4 (9%)
Electrolyte abnormalities1 (1%)1 (2%)0 (0%)
Other44 (49%)15 (33%)29 (66%)
Adverse eventTotal (n = 23)TRE (n = 10)HE (n = 13)
Hunger15 (17%)12 (27%)3 (7%)
Fatigue2 (2%)1 (2%)1 (2%)
Irritability5 (6%)4 (10%)1 (2%)
Headache1 (1%)1 (2%)0 (0%)
Gastrointestinal distress11 (13%)5 (11%)6 (14%)
Dizziness1 (1%)1 (2%)0 (0%)
Lightheadedness9 (10%)5 (11%)4 (9%)
Electrolyte abnormalities1 (1%)1 (2%)0 (0%)
Other44 (49%)15 (33%)29 (66%)

Data are presented as number of events n (%).

Table 3:

Adverse events related or possibly related to the intervention.

Adverse eventTotal (n = 23)TRE (n = 10)HE (n = 13)
Hunger15 (17%)12 (27%)3 (7%)
Fatigue2 (2%)1 (2%)1 (2%)
Irritability5 (6%)4 (10%)1 (2%)
Headache1 (1%)1 (2%)0 (0%)
Gastrointestinal distress11 (13%)5 (11%)6 (14%)
Dizziness1 (1%)1 (2%)0 (0%)
Lightheadedness9 (10%)5 (11%)4 (9%)
Electrolyte abnormalities1 (1%)1 (2%)0 (0%)
Other44 (49%)15 (33%)29 (66%)
Adverse eventTotal (n = 23)TRE (n = 10)HE (n = 13)
Hunger15 (17%)12 (27%)3 (7%)
Fatigue2 (2%)1 (2%)1 (2%)
Irritability5 (6%)4 (10%)1 (2%)
Headache1 (1%)1 (2%)0 (0%)
Gastrointestinal distress11 (13%)5 (11%)6 (14%)
Dizziness1 (1%)1 (2%)0 (0%)
Lightheadedness9 (10%)5 (11%)4 (9%)
Electrolyte abnormalities1 (1%)1 (2%)0 (0%)
Other44 (49%)15 (33%)29 (66%)

Data are presented as number of events n (%).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close